1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline
2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation
3. Key Findings of the Study
4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Industry Value Chain Analysis
4.7. Industry Regulations
4.8. Scenario Analysis
5. Middle East and Africa Minimally Invasive Surgical Instruments Market Forecast by Product Type (US$ Billion)
5.1. Introduction
5.2. Surgical Equipment
5.3. Monitoring & Visualization Equipment
5.4. Electrosurgical Systems
6. Middle East and Africa Minimally Invasive Surgical Instruments Market Forecast by Application (US$ Billion)
6.1. Introduction
6.2. Cardiothoracic Surgery
6.3. Gastrointestinal Surgery
6.4. Orthopedic Surgery
6.5. Gynecological Surgery
6.6. Cosmetic/Bariatric Surgery
6.7. Vascular Surgery
6.8. Urological Surgery
6.9. Others
7. Middle East and Africa Minimally Invasive Surgical Instruments Market Forecast by Geography (US$ Billion)
7.1. Introduction
7.2. Middle East and Africa
7.2.1. Israel
7.2.2. U.A.E.
7.2.3. Qatar
8. Competitive Intelligence
8.1. Market Share Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals
9. Company Profiles
9.1. Ethicon, Inc.
9.1.1. Overview
9.1.2. Financials
9.1.3. Products and Services
9.1.4. Key Developments
9.2. Zimmer, Inc.
9.2.1. Overview
9.2.2. Financials
9.2.3. Products and Services
9.2.4. Key Developments
9.3. Medtronic Plc.
9.3.1. Overview
9.3.2. Financials
9.3.3. Products and Services
9.3.4. Key Developments
9.4. Smith and Nephew
9.4.1. Overview
9.4.2. Financials
9.4.3. Products and Services
9.4.4. Key Developments
9.5. Stryker
9.5.1. Overview
9.5.2. Financials
9.5.3. Products and Services
9.5.4. Key Developments
9.6. CONMED Corporation
9.6.1. Overview
9.6.2. Financials
9.6.3. Products and Services
9.6.4. Key Developments
9.7. Aesculap, Inc.
9.7.1. Overview
9.7.2. Financials
9.7.3. Products and Services
9.7.4. Key Developments
9.8. Abbott Laboratories
9.8.1. Overview
9.8.2. Financials
9.8.3. Products and Services
9.8.4. Key Developments
9.9. Applied Biomedical Resources Corporation
9.9.1. Overview
9.9.2. Financials
9.9.3. Products and Services
9.9.4. Key Developments